Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Advanced Semiconductor Engineering (ADR) (ASX)

Page 1 of 2

In the 21st century investor’s toolkit, there are dozens of gauges investors can use to watch publicly traded companies. Two of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can beat the broader indices by a significant amount (see just how much).

Equally as crucial, positive insider trading sentiment is another way to analyze the stock market universe. As the old adage goes: there are a number of incentives for an insider to sell shares of his or her company, but only one, very clear reason why they would buy. Several academic studies have demonstrated the valuable potential of this method if piggybackers know what to do (learn more here).

Advanced Semiconductor Engineering (ADR) (NYSE:ASX)

Furthermore, let’s analyze the latest info for Advanced Semiconductor Engineering (ADR) (NYSE:ASX).

How are hedge funds trading Advanced Semiconductor Engineering (ADR) (NYSE:ASX)?

Heading into Q3, a total of 9 of the hedge funds we track were long in this stock, a change of 29% from the first quarter. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were upping their holdings meaningfully.

Out of the hedge funds we follow, Ken Fisher’s Fisher Asset Management had the most valuable position in Advanced Semiconductor Engineering (ADR) (NYSE:ASX), worth close to $26.3 million, accounting for 0.1% of its total 13F portfolio. The second largest stake is held by Renaissance Technologies, managed by Jim Simons, which held a $2.4 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other peers that hold long positions include Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Israel Englander’s Millennium Management and Ken Griffin’s Citadel Investment Group.

As aggregate interest spiked, particular hedge funds were breaking ground themselves. Fisher Asset Management, managed by Ken Fisher, created the most outsized position in Advanced Semiconductor Engineering (ADR) (NYSE:ASX). Fisher Asset Management had 26.3 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $2.4 million investment in the stock during the quarter. The following funds were also among the new ASX investors: Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Israel Englander’s Millennium Management, and Ken Griffin’s Citadel Investment Group.

What have insiders been doing with Advanced Semiconductor Engineering (ADR) (NYSE:ASX)?

Insider buying made by high-level executives is most useful when the primary stock in question has experienced transactions within the past half-year. Over the last six-month time frame, Advanced Semiconductor Engineering (ADR) (NYSE:ASX) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Advanced Semiconductor Engineering (ADR) (NYSE:ASX). These stocks are KLA-Tencor Corporation (NASDAQ:KLAC), United Microelectronics Corp (ADR) (NYSE:UMC), Synopsys, Inc. (NASDAQ:SNPS), Lam Research Corporation (NASDAQ:LRCX), and Cree, Inc. (NASDAQ:CREE). All of these stocks are in the semiconductor equipment & materials industry and their market caps are closest to ASX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!